

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of phagocytosis (GO:0050765) | 5.56249908 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19711529 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 4.57131444 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.36840158 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.36840158 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.30802918 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30802918 |
| 8 | definitive hemopoiesis (GO:0060216) | 4.29105949 |
| 9 | neutrophil mediated immunity (GO:0002446) | 4.25679189 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.01786536 |
| 11 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.99520043 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 3.93895088 |
| 13 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.90761903 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87266638 |
| 15 | detection of other organism (GO:0098543) | 3.82825304 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.82180499 |
| 17 | ribosomal small subunit assembly (GO:0000028) | 3.77385328 |
| 18 | response to fungus (GO:0009620) | 3.71145401 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.69153672 |
| 20 | sequestering of metal ion (GO:0051238) | 3.66427965 |
| 21 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.54269899 |
| 22 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.54269899 |
| 23 | defense response to fungus (GO:0050832) | 3.53510350 |
| 24 | pinocytosis (GO:0006907) | 3.51450972 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.46663289 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.46286545 |
| 27 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.45918847 |
| 28 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.45918847 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43034055 |
| 30 | myeloid leukocyte mediated immunity (GO:0002444) | 3.40923918 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39869871 |
| 32 | detection of bacterium (GO:0016045) | 3.39863268 |
| 33 | respiratory burst (GO:0045730) | 3.37450615 |
| 34 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.36791570 |
| 35 | necroptotic process (GO:0070266) | 3.36778920 |
| 36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34169822 |
| 37 | response to peptidoglycan (GO:0032494) | 3.34036357 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.32077225 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31518211 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31426582 |
| 41 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.27611376 |
| 42 | response to host immune response (GO:0052572) | 3.26337831 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26337831 |
| 44 | negative regulation of type 2 immune response (GO:0002829) | 3.23935177 |
| 45 | macrophage differentiation (GO:0030225) | 3.22974489 |
| 46 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.22615778 |
| 47 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.22607981 |
| 48 | regulation of growth of symbiont in host (GO:0044126) | 3.22607981 |
| 49 | negative regulation of growth of symbiont in host (GO:0044130) | 3.22607981 |
| 50 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.22607981 |
| 51 | germinal center formation (GO:0002467) | 3.22053763 |
| 52 | neutrophil activation (GO:0042119) | 3.21381553 |
| 53 | macrophage activation (GO:0042116) | 3.20724229 |
| 54 | positive regulation of mast cell activation (GO:0033005) | 3.20305871 |
| 55 | response to host (GO:0075136) | 3.17172393 |
| 56 | response to host defenses (GO:0052200) | 3.17172393 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.17172393 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.16113922 |
| 59 | keratan sulfate catabolic process (GO:0042340) | 3.15027862 |
| 60 | negative regulation of interleukin-17 production (GO:0032700) | 3.11914132 |
| 61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.11870067 |
| 62 | leukotriene metabolic process (GO:0006691) | 3.11706088 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.07472187 |
| 64 | actin nucleation (GO:0045010) | 3.06511602 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.02199068 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 3.00757690 |
| 67 | cellular response to zinc ion (GO:0071294) | 2.99678860 |
| 68 | angiogenesis involved in wound healing (GO:0060055) | 2.99457458 |
| 69 | regulation of necroptotic process (GO:0060544) | 2.97644245 |
| 70 | regulation of tolerance induction (GO:0002643) | 2.96777172 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96085100 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 2.95432525 |
| 73 | leukocyte aggregation (GO:0070486) | 2.94962889 |
| 74 | microglial cell activation (GO:0001774) | 2.93640534 |
| 75 | blood vessel maturation (GO:0001955) | 2.92964005 |
| 76 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92823314 |
| 77 | defense response to protozoan (GO:0042832) | 2.92774455 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92755771 |
| 79 | regulation of macrophage cytokine production (GO:0010935) | 2.92692888 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 2.92216680 |
| 81 | positive regulation of mast cell degranulation (GO:0043306) | 2.88863132 |
| 82 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.88863132 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 2.84081721 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.83806507 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81904434 |
| 86 | response to protozoan (GO:0001562) | 2.81850567 |
| 87 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.81408595 |
| 88 | regulation of type 2 immune response (GO:0002828) | 2.81249797 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79791701 |
| 90 | granulocyte activation (GO:0036230) | 2.79347745 |
| 91 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.79295658 |
| 92 | reactive oxygen species biosynthetic process (GO:1903409) | 2.79178442 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77126823 |
| 94 | programmed necrotic cell death (GO:0097300) | 2.75318245 |
| 95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74915079 |
| 96 | megakaryocyte development (GO:0035855) | 2.73509337 |
| 97 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73317071 |
| 98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72908152 |
| 99 | regulation of B cell differentiation (GO:0045577) | 2.72420366 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 2.70734667 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 2.68415459 |
| 102 | tolerance induction (GO:0002507) | 2.68212664 |
| 103 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67975469 |
| 104 | modulation by symbiont of host immune response (GO:0052553) | 2.67308808 |
| 105 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67308808 |
| 106 | modulation by symbiont of host defense response (GO:0052031) | 2.67308808 |
| 107 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67308808 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67308808 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67308808 |
| 110 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67295346 |
| 111 | myeloid dendritic cell activation (GO:0001773) | 2.66665149 |
| 112 | regulation of mast cell degranulation (GO:0043304) | 2.66207785 |
| 113 | superoxide anion generation (GO:0042554) | 2.65817187 |
| 114 | neutrophil chemotaxis (GO:0030593) | 2.65509440 |
| 115 | T-helper 1 type immune response (GO:0042088) | 2.64642153 |
| 116 | peptide catabolic process (GO:0043171) | 2.64621747 |
| 117 | negative regulation of mast cell activation (GO:0033004) | 2.63536986 |
| 118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.62664722 |
| 119 | negative regulation of interleukin-6 production (GO:0032715) | 2.61398572 |
| 120 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.61319243 |
| 121 | regulation of natural killer cell differentiation (GO:0032823) | 2.60979595 |
| 122 | regulation of interleukin-17 production (GO:0032660) | 2.60788733 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.60220387 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59460706 |
| 125 | cellular extravasation (GO:0045123) | 2.59395694 |
| 126 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59346635 |
| 127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59222454 |
| 128 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.58254210 |
| 129 | neutrophil migration (GO:1990266) | 2.58217265 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.57085671 |
| 131 | heparin biosynthetic process (GO:0030210) | 2.57036784 |
| 132 | heparin metabolic process (GO:0030202) | 2.57036784 |
| 133 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56708164 |
| 134 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.55164558 |
| 135 | surfactant homeostasis (GO:0043129) | 2.55070665 |
| 136 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.54856327 |
| 137 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54799670 |
| 138 | leukotriene biosynthetic process (GO:0019370) | 2.54216496 |
| 139 | positive regulation of lamellipodium assembly (GO:0010592) | 2.54015543 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.53733139 |
| 141 | response to muramyl dipeptide (GO:0032495) | 2.53428583 |
| 142 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.53082852 |
| 143 | signal peptide processing (GO:0006465) | 2.52263656 |
| 144 | necrotic cell death (GO:0070265) | 2.51993189 |
| 145 | response to interferon-alpha (GO:0035455) | 2.51736515 |
| 146 | regulation of phagocytosis (GO:0050764) | 2.50091737 |
| 147 | germ cell migration (GO:0008354) | 2.49316752 |
| 148 | negative regulation of B cell proliferation (GO:0030889) | 2.45217056 |
| 149 | pentose-phosphate shunt (GO:0006098) | 2.44030664 |
| 150 | negative regulation of granulocyte differentiation (GO:0030853) | 2.39762477 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39636831 |
| 152 | secretory granule organization (GO:0033363) | 2.37282246 |
| 153 | histone-serine phosphorylation (GO:0035404) | 2.37220131 |
| 154 | positive regulation of macrophage differentiation (GO:0045651) | 2.34792253 |
| 155 | B cell receptor signaling pathway (GO:0050853) | 2.33834017 |
| 156 | IMP metabolic process (GO:0046040) | 2.32949108 |
| 157 | killing of cells of other organism (GO:0031640) | 2.31592019 |
| 158 | disruption of cells of other organism (GO:0044364) | 2.31592019 |
| 159 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.29929458 |
| 160 | regulation of erythrocyte differentiation (GO:0045646) | 2.29695738 |
| 161 | regulation of DNA endoreduplication (GO:0032875) | 2.29036071 |
| 162 | toxin transport (GO:1901998) | 2.28631797 |
| 163 | regulation of RIG-I signaling pathway (GO:0039535) | 2.28592473 |
| 164 | response to interferon-beta (GO:0035456) | 2.28443020 |
| 165 | regulation of necrotic cell death (GO:0010939) | 2.28151743 |
| 166 | dendritic cell migration (GO:0036336) | 2.28121367 |
| 167 | endosome to melanosome transport (GO:0035646) | 2.27923098 |
| 168 | endosome to pigment granule transport (GO:0043485) | 2.27923098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.41965214 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.94497286 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.93186698 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87683078 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.80992946 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64461752 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32052688 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.29368215 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10017923 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.03126002 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02898309 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.98115780 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81986783 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72783381 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66514850 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64479610 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50546300 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.45757485 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34660612 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.34653780 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34257597 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25769781 |
| 23 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.23006255 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21371024 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18657582 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13063285 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08217825 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07320510 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00751350 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00020564 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92248566 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90863874 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.86759632 |
| 34 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86442949 |
| 35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.85655966 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82762116 |
| 37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.80033338 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79345354 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76053558 |
| 40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75031132 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73470996 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71208038 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69514661 |
| 44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.64792749 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.63934335 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56544257 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55425893 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54779413 |
| 49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51525238 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51080261 |
| 51 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50539997 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49499199 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49117962 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45621758 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44527538 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44439412 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44276391 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43891662 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.42384176 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41769843 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41210833 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39620576 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.39397320 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.38719626 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.36202114 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33715335 |
| 67 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.30279521 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26779930 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26609471 |
| 70 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26362331 |
| 71 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25380146 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24201699 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23164385 |
| 74 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.19655696 |
| 75 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19023711 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18729373 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16165114 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14975131 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14057441 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13993915 |
| 81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12551431 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10448778 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10168601 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08499811 |
| 85 | * MAF_26560356_Chip-Seq_TH2_Human | 1.08186683 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07284664 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07004721 |
| 88 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.06504424 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05872150 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04843700 |
| 91 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04667071 |
| 92 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03755330 |
| 93 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03307569 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02706403 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02223047 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00556589 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98282584 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98089006 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96813216 |
| 100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96698974 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96623796 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96545382 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92957759 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90182089 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89821300 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88259886 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88196860 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86649444 |
| 109 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86565458 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86274993 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86274993 |
| 112 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84798355 |
| 113 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84120865 |
| 114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84003726 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83635974 |
| 116 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83219615 |
| 117 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81764149 |
| 118 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81682090 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81650867 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80528700 |
| 121 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.79660661 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79637171 |
| 123 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.79331025 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79302866 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78849147 |
| 126 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78836397 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75295590 |
| 128 | TP53_16413492_ChIP-PET_HCT116_Human | 0.73844089 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72516018 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71729402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.36472571 |
| 2 | MP0006054_spinal_hemorrhage | 2.81643436 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.74322275 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.66379306 |
| 5 | MP0003436_decreased_susceptibility_to | 2.49862990 |
| 6 | MP0009785_altered_susceptibility_to | 2.34667618 |
| 7 | MP0002419_abnormal_innate_immunity | 2.33000146 |
| 8 | MP0001958_emphysema | 2.27128860 |
| 9 | MP0003724_increased_susceptibility_to | 2.26100658 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.24317402 |
| 11 | MP0005503_abnormal_tendon_morphology | 2.24172726 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.23441392 |
| 13 | MP0005275_abnormal_skin_tensile | 2.22227578 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.13604927 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.13604927 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.12800613 |
| 17 | MP0003303_peritoneal_inflammation | 2.11070440 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.00978343 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.98118327 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.97325031 |
| 21 | MP0005025_abnormal_response_to | 1.95945082 |
| 22 | MP0004510_myositis | 1.93207353 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.82757428 |
| 24 | MP0004782_abnormal_surfactant_physiolog | 1.81129364 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.79175448 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.72066961 |
| 27 | MP0000685_abnormal_immune_system | 1.71794857 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.68969482 |
| 29 | MP0000343_altered_response_to | 1.68417737 |
| 30 | MP0001819_abnormal_immune_cell | 1.67135224 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.65944234 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.63456932 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.60512427 |
| 34 | MP0005671_abnormal_response_to | 1.59573572 |
| 35 | MP0008004_abnormal_stomach_pH | 1.58922949 |
| 36 | MP0002006_tumorigenesis | 1.58230166 |
| 37 | MP0001800_abnormal_humoral_immune | 1.55725379 |
| 38 | MP0000604_amyloidosis | 1.54909851 |
| 39 | MP0002723_abnormal_immune_serum | 1.54640830 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.53674950 |
| 41 | MP0008260_abnormal_autophagy | 1.52491068 |
| 42 | MP0005451_abnormal_body_composition | 1.51535874 |
| 43 | MP0002398_abnormal_bone_marrow | 1.49221739 |
| 44 | MP0004883_abnormal_blood_vessel | 1.48361000 |
| 45 | MP0002933_joint_inflammation | 1.48315703 |
| 46 | MP0002405_respiratory_system_inflammati | 1.48017933 |
| 47 | MP0001873_stomach_inflammation | 1.47979456 |
| 48 | MP0010307_abnormal_tumor_latency | 1.46141032 |
| 49 | MP0003279_aneurysm | 1.44848959 |
| 50 | MP0009840_abnormal_foam_cell | 1.42531819 |
| 51 | MP0006082_CNS_inflammation | 1.41961274 |
| 52 | MP0001790_abnormal_immune_system | 1.41500581 |
| 53 | MP0005387_immune_system_phenotype | 1.41500581 |
| 54 | MP0000716_abnormal_immune_system | 1.36909533 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.34762353 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 1.34078241 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.33747370 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.33593616 |
| 59 | MP0009278_abnormal_bone_marrow | 1.29816029 |
| 60 | MP0000858_altered_metastatic_potential | 1.29724811 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.27946319 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.27938483 |
| 63 | MP0002429_abnormal_blood_cell | 1.24985258 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.24701964 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.24454391 |
| 66 | MP0002060_abnormal_skin_morphology | 1.23372534 |
| 67 | MP0001853_heart_inflammation | 1.23315808 |
| 68 | MP0005166_decreased_susceptibility_to | 1.22749748 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.22405496 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.21045005 |
| 71 | MP0000490_abnormal_crypts_of | 1.19926340 |
| 72 | MP0003448_altered_tumor_morphology | 1.19795503 |
| 73 | MP0005310_abnormal_salivary_gland | 1.19242246 |
| 74 | MP0002722_abnormal_immune_system | 1.18714570 |
| 75 | MP0003763_abnormal_thymus_physiology | 1.16330997 |
| 76 | MP0001851_eye_inflammation | 1.15630031 |
| 77 | MP0005390_skeleton_phenotype | 1.15331336 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.15006781 |
| 79 | MP0003690_abnormal_glial_cell | 1.14664498 |
| 80 | MP0008469_abnormal_protein_level | 1.07979622 |
| 81 | MP0005023_abnormal_wound_healing | 1.05578624 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 1.04854691 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02282063 |
| 84 | MP0003795_abnormal_bone_structure | 1.01395677 |
| 85 | MP0001542_abnormal_bone_strength | 1.00020085 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.98406214 |
| 87 | MP0010368_abnormal_lymphatic_system | 0.97618568 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.95917777 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.94017889 |
| 90 | MP0004147_increased_porphyrin_level | 0.93642280 |
| 91 | MP0005164_abnormal_response_to | 0.92882922 |
| 92 | MP0004947_skin_inflammation | 0.92302612 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.91115263 |
| 94 | MP0003828_pulmonary_edema | 0.90736854 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.89878585 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.89217029 |
| 97 | MP0009764_decreased_sensitivity_to | 0.88143452 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.86717071 |
| 99 | MP0000249_abnormal_blood_vessel | 0.86270648 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.86003875 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.85504847 |
| 102 | MP0003943_abnormal_hepatobiliary_system | 0.85344828 |
| 103 | MP0010094_abnormal_chromosome_stability | 0.85327221 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.84906032 |
| 105 | MP0003091_abnormal_cell_migration | 0.81807871 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.80002284 |
| 107 | MP0003866_abnormal_defecation | 0.79859458 |
| 108 | MP0003075_altered_response_to | 0.76872194 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.75416563 |
| 110 | MP0002009_preneoplasia | 0.75310039 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.75043126 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.72845185 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.72275102 |
| 114 | MP0001243_abnormal_dermal_layer | 0.72117913 |
| 115 | MP0009763_increased_sensitivity_to | 0.71907118 |
| 116 | MP0002133_abnormal_respiratory_system | 0.70713557 |
| 117 | MP0005388_respiratory_system_phenotype | 0.70713557 |
| 118 | MP0000920_abnormal_myelination | 0.70055627 |
| 119 | MP0003329_amyloid_beta_deposits | 0.69689488 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.68937788 |
| 121 | MP0002132_abnormal_respiratory_system | 0.68785099 |
| 122 | MP0001175_abnormal_lung_morphology | 0.67878568 |
| 123 | MP0003045_fibrosis | 0.64331121 |
| 124 | MP0001663_abnormal_digestive_system | 0.63572595 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.62957778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.48683035 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.48683035 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.48683035 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.12824683 |
| 5 | Thrombocytosis (HP:0001894) | 4.11621714 |
| 6 | Stomatitis (HP:0010280) | 3.87145362 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.72823534 |
| 8 | Optic neuritis (HP:0100653) | 3.72823534 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.67470901 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.47895361 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.27393052 |
| 12 | Spontaneous hematomas (HP:0007420) | 3.20134145 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 3.09290075 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.08683612 |
| 15 | Cervical subluxation (HP:0003308) | 3.07571905 |
| 16 | Hematochezia (HP:0002573) | 3.06138187 |
| 17 | Protrusio acetabuli (HP:0003179) | 2.99450781 |
| 18 | Petechiae (HP:0000967) | 2.97852202 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88911030 |
| 20 | Beaking of vertebral bodies (HP:0004568) | 2.88682543 |
| 21 | Myositis (HP:0100614) | 2.88354558 |
| 22 | Interstitial pulmonary disease (HP:0006530) | 2.83123398 |
| 23 | IgM deficiency (HP:0002850) | 2.79031352 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78825712 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 2.77746574 |
| 26 | Abnormal number of erythroid precursors (HP:0012131) | 2.77117745 |
| 27 | Abnormal platelet function (HP:0011869) | 2.74856208 |
| 28 | Impaired platelet aggregation (HP:0003540) | 2.74856208 |
| 29 | Amyloidosis (HP:0011034) | 2.74714843 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.71505803 |
| 31 | Disinhibition (HP:0000734) | 2.68761209 |
| 32 | Obstructive lung disease (HP:0006536) | 2.68105352 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68105352 |
| 34 | Loss of speech (HP:0002371) | 2.66481447 |
| 35 | Ankle contracture (HP:0006466) | 2.65870884 |
| 36 | Chronic otitis media (HP:0000389) | 2.64570825 |
| 37 | Recurrent fungal infections (HP:0002841) | 2.63607522 |
| 38 | Aplastic anemia (HP:0001915) | 2.63576225 |
| 39 | Premature rupture of membranes (HP:0001788) | 2.60422721 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60196747 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60196747 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60196747 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.59204890 |
| 44 | Osteolytic defects of the hand bones (HP:0009699) | 2.59204890 |
| 45 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.56998959 |
| 46 | Epistaxis (HP:0000421) | 2.54847805 |
| 47 | Abnormality of the lumbar spine (HP:0100712) | 2.52924617 |
| 48 | Recurrent viral infections (HP:0004429) | 2.52624454 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52517760 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.46794765 |
| 51 | Periodontitis (HP:0000704) | 2.46601698 |
| 52 | Abnormal platelet volume (HP:0011876) | 2.43302271 |
| 53 | Cellulitis (HP:0100658) | 2.43267005 |
| 54 | Encephalitis (HP:0002383) | 2.42179774 |
| 55 | Chest pain (HP:0100749) | 2.39939280 |
| 56 | Myocardial infarction (HP:0001658) | 2.38289534 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.38279560 |
| 58 | Spondylolisthesis (HP:0003302) | 2.37767385 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.32084855 |
| 60 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.31831313 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31747922 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.30562788 |
| 63 | Recurrent skin infections (HP:0001581) | 2.30476364 |
| 64 | Gingivitis (HP:0000230) | 2.29160473 |
| 65 | Increased IgE level (HP:0003212) | 2.28586678 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.27847745 |
| 67 | Aortic dissection (HP:0002647) | 2.26495833 |
| 68 | Papilledema (HP:0001085) | 2.26235517 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.25531662 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.25388224 |
| 71 | Absent frontal sinuses (HP:0002688) | 2.21761587 |
| 72 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.21484330 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.20985499 |
| 74 | Meningitis (HP:0001287) | 2.18119823 |
| 75 | Episodic fever (HP:0001954) | 2.15354257 |
| 76 | Pulmonary embolism (HP:0002204) | 2.14684872 |
| 77 | Aortic aneurysm (HP:0004942) | 2.14354233 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 2.14014182 |
| 79 | Osteomyelitis (HP:0002754) | 2.12671926 |
| 80 | Peritonitis (HP:0002586) | 2.12667755 |
| 81 | Epiphyseal dysplasia (HP:0002656) | 2.11765386 |
| 82 | Gingival bleeding (HP:0000225) | 2.11435455 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11270504 |
| 84 | Abnormality of macrophages (HP:0004311) | 2.10130797 |
| 85 | Albinism (HP:0001022) | 2.09225257 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 2.09033015 |
| 87 | Leukocytosis (HP:0001974) | 2.07413160 |
| 88 | Thoracolumbar scoliosis (HP:0002944) | 2.06928101 |
| 89 | Arterial thrombosis (HP:0004420) | 2.05786165 |
| 90 | Orchitis (HP:0100796) | 2.05435227 |
| 91 | Abnormal foot bone ossification (HP:0010675) | 2.04174444 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.00358938 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.00241984 |
| 94 | Increased mean platelet volume (HP:0011877) | 2.00147086 |
| 95 | Vasculitis (HP:0002633) | 1.99232050 |
| 96 | Neurofibrillary tangles (HP:0002185) | 1.97650581 |
| 97 | Recurrent cutaneous fungal infections (HP:0011370) | 1.97416684 |
| 98 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.97416684 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 1.97111136 |
| 100 | Abnormality of T cells (HP:0002843) | 1.96901251 |
| 101 | Hemoptysis (HP:0002105) | 1.95932993 |
| 102 | Increased cerebral lipofuscin (HP:0011813) | 1.95810897 |
| 103 | Pustule (HP:0200039) | 1.95646375 |
| 104 | Slender build (HP:0001533) | 1.95540537 |
| 105 | Purpura (HP:0000979) | 1.93539747 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 1.92780312 |
| 107 | Long clavicles (HP:0000890) | 1.92716102 |
| 108 | Gangrene (HP:0100758) | 1.92577307 |
| 109 | Increased IgM level (HP:0003496) | 1.92419251 |
| 110 | Hypergammaglobulinemia (HP:0010702) | 1.92113968 |
| 111 | Granulocytopenia (HP:0001913) | 1.91982229 |
| 112 | Thoracic kyphosis (HP:0002942) | 1.91924846 |
| 113 | Eosinophilia (HP:0001880) | 1.91610001 |
| 114 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88711896 |
| 115 | Recurrent pneumonia (HP:0006532) | 1.88614288 |
| 116 | Glomerulopathy (HP:0100820) | 1.87596473 |
| 117 | Inflammation of the large intestine (HP:0002037) | 1.87389510 |
| 118 | Fatigue (HP:0012378) | 1.87244614 |
| 119 | Spinal cord lesions (HP:0100561) | 1.86952074 |
| 120 | Syringomyelia (HP:0003396) | 1.86952074 |
| 121 | Abnormality of the peritoneum (HP:0002585) | 1.86930757 |
| 122 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.86857381 |
| 123 | Slender long bone (HP:0003100) | 1.85568209 |
| 124 | Bruising susceptibility (HP:0000978) | 1.85113603 |
| 125 | Soft skin (HP:0000977) | 1.84697909 |
| 126 | Abnormality of T cell number (HP:0011839) | 1.83556231 |
| 127 | Abnormality of the frontal sinuses (HP:0002687) | 1.83494557 |
| 128 | Diminished motivation (HP:0000745) | 1.83222575 |
| 129 | Mutism (HP:0002300) | 1.83123960 |
| 130 | Acute myeloid leukemia (HP:0004808) | 1.82731624 |
| 131 | T lymphocytopenia (HP:0005403) | 1.82669876 |
| 132 | Apathy (HP:0000741) | 1.82358573 |
| 133 | Broad metatarsal (HP:0001783) | 1.81405532 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.81139518 |
| 135 | Metaphyseal dysplasia (HP:0100255) | 1.81104510 |
| 136 | Gastrointestinal inflammation (HP:0004386) | 1.80411261 |
| 137 | Cupped ribs (HP:0000887) | 1.78605843 |
| 138 | Premature loss of primary teeth (HP:0006323) | 1.78526817 |
| 139 | Polyneuropathy (HP:0001271) | 1.78469025 |
| 140 | Urticaria (HP:0001025) | 1.77888282 |
| 141 | Hypoplasia of the thymus (HP:0000778) | 1.77063422 |
| 142 | Abnormality of the fingertips (HP:0001211) | 1.76673898 |
| 143 | Thickened calvaria (HP:0002684) | 1.74694625 |
| 144 | Patchy hypopigmentation of hair (HP:0011365) | 1.73900860 |
| 145 | Colitis (HP:0002583) | 1.73686328 |
| 146 | Increased CSF protein (HP:0002922) | 1.73471042 |
| 147 | Hepatosplenomegaly (HP:0001433) | 1.73450483 |
| 148 | Conjunctival telangiectasia (HP:0000524) | 1.73376806 |
| 149 | Mucopolysacchariduria (HP:0008155) | 1.73086913 |
| 150 | Increased serum ferritin (HP:0003281) | 1.73082245 |
| 151 | Slow saccadic eye movements (HP:0000514) | 1.72691584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 3.37198714 |
| 2 | IRAK4 | 3.28219137 |
| 3 | PRPF4B | 3.16607631 |
| 4 | MAP3K3 | 2.78470343 |
| 5 | TEC | 2.71991012 |
| 6 | KIT | 2.67691198 |
| 7 | MAP4K1 | 2.47336308 |
| 8 | TRPM7 | 2.46901435 |
| 9 | TAOK3 | 2.45506602 |
| 10 | BTK | 2.01662961 |
| 11 | TTN | 1.99644561 |
| 12 | FRK | 1.97309819 |
| 13 | TGFBR2 | 1.87093533 |
| 14 | MAP3K14 | 1.86740179 |
| 15 | RPS6KA4 | 1.81181167 |
| 16 | BRSK2 | 1.77419590 |
| 17 | BMPR2 | 1.70121207 |
| 18 | GRK7 | 1.69978688 |
| 19 | TYK2 | 1.60925890 |
| 20 | FGR | 1.56350595 |
| 21 | FLT3 | 1.55661304 |
| 22 | EEF2K | 1.52270760 |
| 23 | PIM2 | 1.50554338 |
| 24 | ZAP70 | 1.49848351 |
| 25 | ERBB3 | 1.49800867 |
| 26 | ERN1 | 1.49458182 |
| 27 | PKN2 | 1.48102149 |
| 28 | TGFBR1 | 1.48012184 |
| 29 | TIE1 | 1.47433587 |
| 30 | FGFR3 | 1.44818336 |
| 31 | TAOK1 | 1.43640351 |
| 32 | SIK3 | 1.43317177 |
| 33 | MOS | 1.40766595 |
| 34 | JAK3 | 1.38386129 |
| 35 | JAK1 | 1.34926631 |
| 36 | NEK9 | 1.33865940 |
| 37 | ZAK | 1.33771705 |
| 38 | TXK | 1.30792531 |
| 39 | VRK1 | 1.30195434 |
| 40 | LRRK2 | 1.30001112 |
| 41 | IRAK3 | 1.29015945 |
| 42 | CSF1R | 1.27863818 |
| 43 | TBK1 | 1.20567968 |
| 44 | CSK | 1.19224897 |
| 45 | STK10 | 1.18951669 |
| 46 | SCYL2 | 1.16797708 |
| 47 | PIK3CG | 1.15074176 |
| 48 | MAP3K1 | 1.14891425 |
| 49 | ITK | 1.14265759 |
| 50 | KSR2 | 1.11481478 |
| 51 | WEE1 | 1.10734312 |
| 52 | MAP3K5 | 1.10061765 |
| 53 | IRAK1 | 1.06519834 |
| 54 | BLK | 1.04521507 |
| 55 | IKBKB | 1.04152409 |
| 56 | FES | 1.03447586 |
| 57 | PIM1 | 1.03019075 |
| 58 | SYK | 1.02441314 |
| 59 | STK24 | 1.01239184 |
| 60 | IRAK2 | 1.00289842 |
| 61 | CDC42BPA | 0.99274517 |
| 62 | NEK2 | 0.96713895 |
| 63 | STK4 | 0.96532288 |
| 64 | NME2 | 0.96104212 |
| 65 | IKBKE | 0.95726492 |
| 66 | PAK4 | 0.95427495 |
| 67 | MARK3 | 0.93214524 |
| 68 | MAPK7 | 0.92165336 |
| 69 | LYN | 0.91561445 |
| 70 | STK16 | 0.89443174 |
| 71 | EIF2AK3 | 0.88985892 |
| 72 | MAP3K6 | 0.80517518 |
| 73 | CDK8 | 0.80357684 |
| 74 | KDR | 0.79953788 |
| 75 | HCK | 0.79451147 |
| 76 | MARK2 | 0.78479512 |
| 77 | CAMKK2 | 0.78435349 |
| 78 | MAP3K11 | 0.76732365 |
| 79 | TRIB3 | 0.73810901 |
| 80 | MATK | 0.73694641 |
| 81 | RIPK1 | 0.73664313 |
| 82 | PTK6 | 0.72105497 |
| 83 | EIF2AK2 | 0.71283533 |
| 84 | RPS6KB2 | 0.70899198 |
| 85 | YES1 | 0.69405463 |
| 86 | PDGFRA | 0.68857427 |
| 87 | JAK2 | 0.68844157 |
| 88 | MYLK | 0.68443430 |
| 89 | KSR1 | 0.67554451 |
| 90 | MAPK12 | 0.67227223 |
| 91 | PRKD2 | 0.66001825 |
| 92 | LCK | 0.65670548 |
| 93 | ACVR1B | 0.65529243 |
| 94 | TESK1 | 0.64600683 |
| 95 | TNK2 | 0.63413528 |
| 96 | CDC7 | 0.61500317 |
| 97 | HIPK2 | 0.61058699 |
| 98 | ATR | 0.60997342 |
| 99 | CDK6 | 0.60114465 |
| 100 | PRKG2 | 0.59754155 |
| 101 | MAP3K2 | 0.59547939 |
| 102 | PDK1 | 0.59452654 |
| 103 | SGK3 | 0.58944090 |
| 104 | CDK12 | 0.58825429 |
| 105 | MKNK1 | 0.58229314 |
| 106 | CHUK | 0.57273374 |
| 107 | SIK2 | 0.56913929 |
| 108 | MAPKAPK5 | 0.55709062 |
| 109 | MAPK4 | 0.50801443 |
| 110 | PDPK1 | 0.50458056 |
| 111 | CDK7 | 0.50186506 |
| 112 | CAMK1D | 0.49582853 |
| 113 | PASK | 0.49230436 |
| 114 | FYN | 0.44743007 |
| 115 | MAPKAPK3 | 0.44351933 |
| 116 | EPHB1 | 0.43954184 |
| 117 | RET | 0.43715521 |
| 118 | ABL1 | 0.43495614 |
| 119 | MAPKAPK2 | 0.43257139 |
| 120 | GRK1 | 0.43048749 |
| 121 | BUB1 | 0.43014298 |
| 122 | MAP3K12 | 0.42646532 |
| 123 | PDGFRB | 0.41168625 |
| 124 | TAOK2 | 0.41130920 |
| 125 | RAF1 | 0.40748547 |
| 126 | PIK3CA | 0.40588082 |
| 127 | DDR2 | 0.38726433 |
| 128 | SGK2 | 0.38692367 |
| 129 | MAP3K13 | 0.38425189 |
| 130 | DYRK1B | 0.38413100 |
| 131 | MAP2K6 | 0.38377545 |
| 132 | EPHA3 | 0.38304197 |
| 133 | AURKB | 0.38071064 |
| 134 | RIPK4 | 0.37654414 |
| 135 | WNK1 | 0.37451800 |
| 136 | GRK6 | 0.37345872 |
| 137 | RPS6KA6 | 0.37216352 |
| 138 | RPS6KC1 | 0.36250764 |
| 139 | RPS6KL1 | 0.36250764 |
| 140 | EGFR | 0.36221136 |
| 141 | NTRK2 | 0.35742578 |
| 142 | TESK2 | 0.34510945 |
| 143 | STK38 | 0.32339090 |
| 144 | BRD4 | 0.32221547 |
| 145 | PTK2B | 0.32185164 |
| 146 | MAP3K7 | 0.31027484 |
| 147 | RPS6KA2 | 0.30851184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76594438 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.52630534 |
| 3 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.49366117 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94623222 |
| 5 | Malaria_Homo sapiens_hsa05144 | 1.90125694 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85418257 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84377660 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82591285 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75775571 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73836947 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.71923487 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.67508103 |
| 13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.63330882 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59372217 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.54327700 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.54034865 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.51118804 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.50607035 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49853940 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.46253775 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45982546 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45685467 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45201149 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43019941 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41760964 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41487201 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.41055646 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.40922945 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.38504911 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.38133314 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.37898337 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37589745 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37509245 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36566050 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35856080 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35270260 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.34212017 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.32918500 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30459760 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29264053 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.28417323 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27732649 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 1.27274898 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25152161 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.23398671 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23103920 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22936840 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 1.19932890 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.18435372 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15601839 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14468786 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13685592 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 1.12705504 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.12161563 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11939940 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06624323 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06394636 |
| 58 | Cell cycle_Homo sapiens_hsa04110 | 1.05544575 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.02473895 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01815810 |
| 61 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99533732 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99341508 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97905548 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97338651 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95709085 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94052970 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93591064 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93449837 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92108885 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90576543 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90384906 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89933155 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.89085105 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88268809 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88056757 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87081963 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86699556 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86002453 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.84832264 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84295660 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84001195 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82720757 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80701309 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80635261 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80307783 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79868899 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77221775 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75666582 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73692197 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72306043 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70078871 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69707511 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68775875 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67808626 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.66818085 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66187751 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65238851 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64418124 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63496758 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62851352 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62320203 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.62302013 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61281294 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.59918269 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59632025 |
| 106 | Allograft rejection_Homo sapiens_hsa05330 | 0.58551260 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57950159 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57401324 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55778949 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55687798 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55095718 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54896501 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54477023 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.54342755 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.53373165 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52917716 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52484393 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52425164 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52406157 |
| 120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51419103 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51343371 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51128375 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50758307 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50147253 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49901735 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49754015 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | 0.48876116 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47268177 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46783960 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.46548504 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46249095 |
| 132 | RNA degradation_Homo sapiens_hsa03018 | 0.45659237 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44926110 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44127369 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43873078 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43630524 |
| 137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40721259 |

